Related Experiment Video
Updated: Jun 8, 2025
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
12.3K
Early Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence
Atehkeng Zinkeng1, F Lloyd Taylor2, Samuel H Cheong3
1Medical Scientist Training Program, University of Arizona College of Medicine, Tucson, Arizona.
Cellular and Molecular Gastroenterology and Hepatology
|November 7, 2024
Summary
Colorectal cancer (CRC) is rising in young adults. This review explores unique risk factors, genetic changes, and potential biomarkers for early-onset CRC, distinct from older patients.
Area of Science:
- Oncology
- Genetics
- Epidemiology
Background:
- Colorectal cancer (CRC) incidence is increasing in individuals under 50.
- Early-onset CRC often lacks hereditary mutations seen in late-onset cases.
- Understanding unique CRC development in younger populations is crucial.
Purpose of the Study:
- To review epidemiologic shifts, risk factors, and clinical/molecular features of early-onset CRC.
- To explore genetic and epigenetic modifications specific to early-onset CRC.
- To discuss the role of noninvasive biomarkers for early detection and prognosis.
Main Methods:
- Literature review of epidemiologic, clinical, and molecular data.
- Analysis of genetic and epigenetic alterations in early-onset CRC.
- Discussion of environmental factors and single-nucleotide polymorphisms (SNPs).
Main Results:
- Early-onset CRC exhibits distinct genetic and epigenetic profiles.
- Synergistic effects of SNPs and environmental factors contribute to early onset.
- Noninvasive biomarkers show promise for improved detection and outcomes.
Conclusions:
- Early-onset CRC pathogenesis differs significantly from late-onset CRC.
- Further research into unique molecular drivers and environmental influences is warranted.
- Biomarker development is key for enhancing early detection and management of early-onset CRC.
Related Concept Videos
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.7K
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
01:33Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K